Trial Profile
The Evaluation of Singulair for the Treatment of Non-Allergic Rhinitis Eosinophil Syndrome (NARES)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Rhinitis
- Focus Therapeutic Use
- 28 Feb 2017 New trial record